Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000249039

Medchemexpress LLC Cp-409092 hydrochloride | 225240-86-8 | 99.8% | 333.81 g/mol | C17H20ClN3O2 | 10 MG
SDP

Catalog No. 5000249039
Encompass_Preferred

CP-409092 hydrochloride is a research-use small molecule described as a partial agonist of GABAA receptors with reported anti-anxiety activity. It is supplied as a solid for laboratory research and is not intended for human therapeutic use.

  • Partial agonist of GABAA receptor, with anti-anxiety activity.
  • High purity: 99.8% (reported).
  • Solid, white to off-white appearance for handling and formulation.
  • Recommended storage: 4°C sealed; in solvent, -80°C (up to 6 months) or -20°C (up to 1 month).
  • Available in small research pack sizes; common pack: 10 MG.
  • For research use only; not for clinical or human use.

Catalog No. 50-002-49039 Supplier Medchemexpress LLC Supplier No. HY101639A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

CP-409092 hydrochloride is a research-use small molecule described as a partial agonist of GABAA receptors with reported anti-anxiety activity. It is supplied as a solid for laboratory research and is not intended for human therapeutic use.

  • Partial agonist of GABAA receptor, with anti-anxiety activity.
  • High purity: 99.8% (reported).
  • Solid, white to off-white appearance for handling and formulation.
  • Recommended storage: 4°C sealed; in solvent, -80°C (up to 6 months) or -20°C (up to 1 month).
  • Available in small research pack sizes; common pack: 10 MG.
  • For research use only; not for clinical or human use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.